There are classic signs of pregnancy such as morning sickness or missing your period, but there are other physical changes that may indicate pregnancy even earlier. Here are 10 common signs of ...

Many gamers around the world experience motion sickness caused by fast-moving visuals, especially in first-person games or during rapid camera movements. One commonly shared trick in online ...

The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday. The approval marks the ...

Does motion sickness turn you into a green, spewing mess? For plenty of people, the answer is yes. Current remedies may or may not help. But after 40 years, the first new motion-sickness drug has been ...

In clinical trials, the incidence of vomiting was significantly lower with tradipitant compared with placebo during boat trips. The Food and Drug Administration (FDA) has approved Nereus™ (tradipitant ...

The FDA delivered a pair of holiday season approvals a week apart, signing off on Agios’ oral medicine Aqvesme for the treatment of anemia in adults with alpha- or beta-thalassemia on Dec. 23, and ...

Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) approving a novel oral pill that helps prevent motion-induced vomiting – the first ...

What Is Nereus, And Why Does It Matter? Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such ...

Our reporter sends a dispatch from the icebreaker Araon, currently on its way to Antarctica, about the scientists, their work and how he’s battling seasickness. By Raymond Zhong Reporting from the ...

Scientists aboard the icebreaker Araon welcomed 2026 with games, another time change and a soup that marks the years ticking past. By Raymond Zhong Reporting from the icebreaker Araon en route to ...

Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are dissatisfied with existing treatments. The FDA has approved Vanda Pharmaceuticals’ ...